Related Experiment Video
Updated: Jul 12, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human
Yunhe Xie1,2, Jiarong Ye3, Hongliang Luo1
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330008, People's Republic of China.
Abstract:
HOXC cluster antisense RNA 3 (HOXC-AS3) is a novel long noncoding RNA (lncRNA) that exhibits aberrant expression patterns in various cancer types. Its expression is closely related to clinicopathological features, demonstrating significant clinical relevance across multiple tumors. And HOXC-AS3 plays multifaceted roles in tumor progression, impacting cell proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT), autophagy, senescence, tumor growth, and metastasis. In this review, we summarized and comprehensively analyzed the expression and clinical significance of HOXC-AS3 as a diagnostic and prognostic biomarker for malignancies. Additionally, we presented an in-depth update on HOXC-AS3's functions and regulatory mechanisms in cancer pathogenesis. This narrative review underscores the importance of HOXC-AS3 as a promising lncRNA candidate in cancer research and its potential as a predictive biomarker and therapeutic target in clinical applications.
Insights
HOXC-AS3, a long noncoding RNA (lncRNA), is frequently altered in cancers and impacts tumor progression. This review highlights its potential as a diagnostic and prognostic biomarker for malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- HOXC cluster antisense RNA 3 (HOXC-AS3) is a novel lncRNA with aberrant expression in various cancer types.
- HOXC-AS3's expression correlates with clinicopathological features, indicating clinical relevance.
Purpose of the Study:
- To review and analyze the expression and clinical significance of HOXC-AS3 in malignancies.
- To provide an update on the functions and regulatory mechanisms of HOXC-AS3 in cancer pathogenesis.
- To underscore HOXC-AS3's potential as a diagnostic, prognostic, and therapeutic target.
Main Methods:
- Literature review and comprehensive analysis of existing studies on HOXC-AS3.
- Synthesis of data regarding HOXC-AS3 expression patterns in different cancers.
- Compilation of evidence on HOXC-AS3's functional roles and regulatory mechanisms in tumor progression.
Main Results:
- HOXC-AS3 exhibits aberrant expression across multiple cancer types.
- HOXC-AS3 influences key cancer processes including proliferation, apoptosis, migration, invasion, EMT, autophagy, and senescence.
- HOXC-AS3 is linked to tumor growth and metastasis.
Conclusions:
- HOXC-AS3 is a promising biomarker for cancer diagnosis and prognosis.
- HOXC-AS3 plays multifaceted roles in cancer development and progression.
- HOXC-AS3 represents a potential therapeutic target for clinical applications in oncology.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Inheritance of Chromatin Structures
Non-LTR Retrotransposons
Hedgehog Signaling Pathway
MicroRNAs

